MARKET

ALDR

Alder
ALDR
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-3.8734
1371.10
7.28
1,579,070,977.92
About ALDR
Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated for migraine prevention. Eptinezumab is a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP), a protein that is active in mediating the initiation of migraine. Alder is additionally evaluating ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine. Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6 and is licensed to Vitaeris, Inc.
More

ALDR News

More
Azelby out as CEO of Alder BioPharmaceuticals following close of $2B acquisition
American City Business Journals · 12/06/2019 01:15
Seattle has potential as a biotech hub, but more companies must stay here and grow
American City Business Journals · 11/22/2019 08:01
4 RNA Therapy Stocks For A Biotech Portfolio
Seeking Alpha - Article · 11/07/2019 19:20
Did Hedge Funds Drop The Ball On On Alder Biopharmaceuticals Inc (ALDR) ?
Insider Monkey · 10/29/2019 00:56
Healthcare And Biotechs Struggle, But Opportunity Ahead
Seeking Alpha - Article · 10/23/2019 06:24
Stocks That Hit 52-Week Highs On Monday
Monday morning saw 215 companies set new 52-week highs.
Benzinga · 10/21/2019 15:06
Jim Cramer Shares His Thoughts On Canopy Growth, Procter & Gamble And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Canopy Growth Corp (NYSE: CGC) needs new CEO for the stock to trade higher.
Benzinga · 10/17/2019 13:15
Cramer's lightning round: Canopy needs a packaged goods CEO
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 10/16/2019 22:54

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Alder stock information, including NASDAQ:ALDR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALDR stock news, and many more online research tools to help you make informed decisions.